There has been growing interest in the development of noninvasive biomarkers for the
diagnosis, quantification, and monitoring of patients with hepatic steatosis and fibrosis.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Clinical RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.J Magn Reson Imaging. 2011; 34 (spcone)
- The natural history of nonalcoholic fatty liver disease: a population-based cohort study.Gastroenterology. 2005; 129: 113-121
- Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.Hepatology. 2004; 40: 1387-1395
- Nonalcoholic fatty liver disease: from steatosis to cirrhosis.Hepatology. 2006; 43: S99-S112
- Nonalcoholic fatty liver disease: a systematic review.JAMA. 2015; 313: 2263-2273
- Liver cirrhosis.Lancet. 2008; 371: 838-851
- The epidemiology of cirrhosis in the United States: a population-based Study.J Clin Gastroenterol. 2015; 49: 690-696
- Cirrhosis and its complications: evidence based treatment.World J Gastroenterol. 2014; 20: 5442-5460
- Emerging therapies for liver fibrosis.Dig Dis. 2006; 24: 174-183
- Reversal of hepatic fibrosis -- fact or fantasy?.Hepatology. 2006; 43: S82-S88
- Liver biopsy.Hepatology. 2009; 49: 1017-1044
- Liver biopsy.N Engl J Med. 2001; 344: 495-500
- Sampling variability of liver biopsy in nonalcoholic fatty liver disease.Gastroenterology. 2005; 128: 1898-1906
- Sampling variability of liver fibrosis in chronic hepatitis C.Hepatology. 2003; 38: 1449-1457
- Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients.New Microbiol. 2016; 39: 110-113
- Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: a multi-centre observational study.PLoS One. 2018; 13: e0192763
- Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications.Hepatology. 2008; 47: 332-342
- Magnetic resonance elastography of liver.Magn Reson Imaging Clin N Am. 2014; 22: 433-446
- Magnetic resonance elastography of liver: technique, analysis, and clinical applications.J Magn Reson Imaging. 2013; 37: 544-555
- Magnetic resonance elastography of liver: clinical applications.J Comput Assist Tomogr. 2013; 37: 887-896
- Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration.J Magn Reson Imaging. 2012; 36: 1011-1014
- Quantification of liver fat with magnetic resonance imaging.Magn Reson Imaging Clin N Am. 2010; 18 (ix): 337-357
- High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.Radiology. 2015; 274: 693-701
- Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes.Diabetes Care. 2012; 35: 717-722
- NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.Am J Gastroenterol. 2009; 104: 861-867
- Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.Dig Liver Dis. 2015; 47: 181-190
- Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.Am J Gastroenterol. 1999; 94: 2467-2474
- Assessment of hepatic steatosis by expert pathologists: the end of a gold standard.Ann Surg. 2009; 250: 691-697
- Quantification of liver fat using magnetic resonance spectroscopy.Magn Reson Imaging. 1994; 12: 487-495
- Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis.J Magn Reson Imaging. 1995; 5: 281-285
- Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography.Invest Radiol. 1993; 28: 297-302
- Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo.Am J Physiol. 1999; 276: E977-E989
- Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis.Radiology. 2018; 286: 486-498
- Simple proton spectroscopic imaging.Radiology. 1984; 153: 189-194
- Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging.Radiology. 2009; 250: 130-136
- Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors.J Magn Reson Imaging. 2008; 28: 678-684
- Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T--feasibility.Radiology. 2008; 247: 550-557
- Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience.Radiology. 2005; 237: 1048-1055
- Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques--initial experience.Radiology. 2005; 237: 507-511
- Relaxation effects in the quantification of fat using gradient echo imaging.Magn Reson Imaging. 2008; 26: 347-359
- Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.Radiology. 2009; 251: 67-76
- Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans.Invest Radiol. 1991; 26: 1041-1052
- Introduction of fast MR imaging in the assessment of hepatic steatosis.Magn Reson Imaging. 1997; 15: 287-293
- Water-fat separation with IDEAL gradient-echo imaging.J Magn Reson Imaging. 2007; 25: 644-652
- Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL.Magn Reson Med. 2008; 59: 521-527
- Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise.Magn Reson Med. 2007; 58: 354-364
- Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation.J Magn Reson Imaging. 2007; 26: 1153-1161
- Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling.Magn Reson Med. 2008; 60: 1122-1134
- Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling.J Magn Reson Imaging. 2009; 29: 1332-1339
- Proton-density fat fraction and simultaneous R2* estimation as an MRI tool for assessment of osteoporosis.Eur Radiol. 2013; 23: 3432-3439
- Magnetic susceptibility as a B0 field strength independent MRI biomarker of liver iron overload.Magn Reson Med. 2013; 70: 648-656
- Quantification of liver iron with MRI: state of the art and remaining challenges.J Magn Reson Imaging. 2014; 40: 1003-1021
- Multipeak fat-corrected complex R2* relaxometry: theory, optimization, and clinical validation.Magn Reson Med. 2013; 70: 1319-1331
- Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.Radiology. 2013; 267: 422-431
- Evaluation of liver fat in the presence of iron with MRI using T2* correction: a clinical approach.Eur Radiol. 2013; 23: 1643-1649
- Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women.Eur Radiol. 2015; 25: 2921-2930
- Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.Abdom Imaging. 2015; 40: 3084-3090
- Quantification of liver fat with respiratory-gated quantitative chemical shift encoded MRI.J Magn Reson Imaging. 2015; 42: 1241-1248
- T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis.J Magn Reson Imaging. 2011; 33: 873-881
- Quantitative magnetic resonance imaging of hepatic steatosis: validation in ex vivo human livers.Hepatology. 2015; 62: 1444-1455
- Standardized approach for ROI-based measurements of proton density fat fraction and R2* in the liver.AJR Am J Roentgenol. 2017; 209: 592-603
- Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.Am J Physiol Endocrinol Metab. 2005; 288: E462-E468
- Quantification of liver fat content: diagnostic evaluation of proton magnetic resonance spectroscopy compared with histological methods.J Hepatol. 2016; 64: S493
- Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis.Hepatology. 2013; 58: 1877-1880
- T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: validation in a fat-water-SPIO phantom.J Magn Reson Imaging. 2009; 30: 1215-1222
- Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice.Radiology. 2010; 254: 119-128
- Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy.Radiology. 2011; 258: 767-775
- Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T.Radiology. 2011; 258: 749-759
- Validation of a motion-robust 2D sequential technique for quantification of hepatic proton density fat fraction during free breathing.J Magn Reson Imaging. 2018; 48: 1578-1585
- High SNR acquisitions improve the repeatability of liver fat quantification using confounder-corrected chemical shift-encoded MR imaging.Magn Reson Med Sci. 2017; 16: 332-339
- Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease.Gastroenterology. 2015; 149: 389-397.e10
- Assessment of hepatic fibrosis with magnetic resonance elastography.Clin Gastroenterol Hepatol. 2007; 5: 1207-1213.e2
- Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C.Magn Reson Med Sci. 2012; 11: 291-297
- Magnetic resonance elastography: feasibility of liver stiffness measurements in healthy volunteers at 3T.Clin Radiol. 2012; 67: 258-262
- MR elastography for noninvasive assessment of hepatic fibrosis: reproducibility of the examination and reproducibility and repeatability of the liver stiffness value measurement.J Magn Reson Imaging. 2014; 39: 326-331
- Magnetic resonance elastography of liver in healthy Asians: normal liver stiffness quantification and reproducibility assessment.J Magn Reson Imaging. 2014; 39: 1-8
- Magnetic resonance elastography for the noninvasive staging of liver fibrosis.Gastroenterology. 2008; 135: 32-40
- Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography.Radiology. 2010; 257: 80-86
- Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis.Invest Radiol. 2013; 48: 607-613
- MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia.J Magn Reson Imaging. 2011; 34: 1110-1116
- Ultrasound elastography and MR elastography for assessing liver fibrosis: part 1, principles and techniques.AJR Am J Roentgenol. 2015; 205: 22-32
- Magnetic resonance elastography: a review.Clin Anat. 2010; 23: 497-511
- Magnetic resonance elastography by direct visualization of propagating acoustic strain waves.Science. 1995; 269: 1854-1857
- In vivo determination of hepatic stiffness using steady-state free precession magnetic resonance elastography.Invest Radiol. 2006; 41: 841-848
- Assessment of liver viscoelasticity using multifrequency MR elastography.Magn Reson Med. 2008; 60: 373-379
- Automated liver elasticity calculation for MR elastography.J Magn Reson Imaging. 2016; 43: 1055-1063
- Pediatric MR elastography of hepatic fibrosis: principles, technique and early clinical experience.Pediatr Radiol. 2012; 42: 402-409
- Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients.Transplantation. 2011; 92: 581-586
- Cross-vendor validation of liver magnetic resonance elastography.Abdom Imaging. 2015; 40: 789-794
- Interplatform reproducibility of liver and spleen stiffness measured with MR elastography.J Magn Reson Imaging. 2016; 43: 1064-1072
- Repeatability of magnetic resonance elastography for quantification of hepatic stiffness.J Magn Reson Imaging. 2010; 31: 725-731
- Repeatability and reproducibility of 2D and 3D hepatic MR elastography with rigid and flexible drivers at end-expiration and end-inspiration in healthy volunteers.Abdom Radiol (NY). 2017; 42: 2843-2854
- MR elastography of liver tumors: preliminary results.AJR Am J Roentgenol. 2008; 190: 1534-1540
- Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography.Radiology. 2011; 259: 749-756
- Magnetic resonance elastography of the liver in patients status-post fontan procedure: feasibility and preliminary results.Congenit Heart Dis. 2014; 9: 7-14
- Performance of magnetic resonance elastography in primary sclerosing cholangitis.J Gastroenterol Hepatol. 2016; 31: 1184-1190
- Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension.AJR Am J Roentgenol. 2009; 193: 122-127
- Magnetic resonance elastography of liver: current update.Top Magn Reson Imaging. 2018; 27: 319-333
- Comparison of diagnostic accuracies of two- and three-dimensional MR elastography of the liver.J Magn Reson Imaging. 2017; 45: 1163-1170
- Assessment of advanced hepatic MR elastography methods for susceptibility artifact suppression in clinical patients.J Magn Reson Imaging. 2018; 47: 976-987
- Can MR elastography be used to measure liver stiffness in patients with iron overload?.Abdom Radiol (NY). 2018; 44: 104-109
- Comparison of standard breath-held, free-breathing, and compressed sensing 2D gradient-recalled echo MR elastography techniques for evaluating liver stiffness.AJR Am J Roentgenol. 2018; 211: W279-W287
Article info
Publication history
Published online: June 03, 2019
Footnotes
Disclosure Statement: M.C. Olson and S.K. Venkatesh: No disclosures. S.B. Reeder: No relevant disclosures. Unrelated: Ownership in Calimetrix, Reveal Pharmaceuticals, Elucent Medical, and Cellectar Biosciences. The authors wish to acknowledge support from the NIH (R01 DK083380, R01 DK088925, R01 DK100651, and K24 DK102595) as well as GE Healthcare, who provide research support to the University of Wisconsin–Madison. Furthermore, S.B. Reeder is a Romnes Faculty Fellow and has received an award provided by the University of Wisconsin–Madison Office of the Vice Chancellor for Research and Graduate Education with funding from the Wisconsin Alumni Research Foundation.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
